Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux

Iryna Voloshyna, Isaac Teboul, Michael J. Littlefield, Nicolle M. Siegart, George K. Turi, Melissa J. Fazzari, Steven E. Carsons, Joshua DeLeon, Allison B. Reiss

Research output: Contribution to journalArticle

16 Scopus citations

Fingerprint Dive into the research topics of 'Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds